Correctional institutions can maximize their funds and improve inmate care by partnering with or becoming 340B covered entities, but doing so can be tricky, experts said during a March 31 webinar. | Shutterstock

Panelists Share Insights on Using 340B in Prisons and Jails

Prisons struggling with the high cost of treating inmates with viral illnesses such as hepatitis C and HIV can turn to the 340B program for relief, but participation is often tricky.

That was the takeaway of “Demystifying 340B for Correctional Institutions” a webinar conducted Wednesday by the National Hepatitis Corrections Network and the National Virus Hepatitis Roundtable. Panelists included medical and pharmacy officials from corrections systems in Alaska, Minnesota, and Rhode Island. Jeff Davis, of counsel with the law firm of Baker Donelson in Washington, D.C., illustrated how the 340B program worked within correctional institutions.

Prisons struggling with the high cost of treating inmates with viral illnesses such as hepatitis C and HIV can turn to the 340B program for relief, but participation is often tricky.

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.
If you are not yet a paid subscriber, please Subscribe now.
For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.
« Read Previous Read Next »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report